Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial

M (Marco) Valgimigli; F (Frederico) Costa; Y Lokhnygina; RM Clare; L Wallentin; DJ Moliterno; PW Armstrong; HD White; C Held; PE Aylward; F van der Werf; RA Harrington; KW Mahaffey; P Tricoci

doi:10.1093/eurheartj/ehw525

Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial

M (Marco) Valgimigli, F (Frederico) Costa, Y Lokhnygina, RM Clare, L Wallentin, DJ Moliterno, PW Armstrong, HD White, C Held, PE Aylward, F van der Werf, RA Harrington, KW Mahaffey, P Tricoci

Cardiology

Research output: Contribution to journal › Article › Academic › peer-review

187 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	804-+
Journal	European Heart Journal
Volume	38
Issue number	11
DOIs	https://doi.org/10.1093/eurheartj/ehw525
Publication status	Published - 2017

Access to Document

10.1093/eurheartj/ehw525

http://hdl.handle.net/1765/99481

Cite this

Valgimigli, M., Costa, F., Lokhnygina, Y., Clare, RM., Wallentin, L., Moliterno, DJ., Armstrong, PW., White, HD., Held, C., Aylward, PE., van der Werf, F., Harrington, RA., Mahaffey, KW., & Tricoci, P. (2017). Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial. European Heart Journal, 38(11), 804-+. https://doi.org/10.1093/eurheartj/ehw525

@article{006e4a8ad1954b0884ab7e5dac4689ac,

title = "Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial",

author = "Valgimigli, {M (Marco)} and Costa, {F (Frederico)} and Y Lokhnygina and RM Clare and L Wallentin and DJ Moliterno and PW Armstrong and HD White and C Held and PE Aylward and {van der Werf}, F and RA Harrington and KW Mahaffey and P Tricoci",

year = "2017",

doi = "10.1093/eurheartj/ehw525",

language = "Undefined/Unknown",

volume = "38",

pages = "804--+",

journal = "European Heart Journal",

issn = "0195-668X",

publisher = "Oxford University Press",

number = "11",

}

Valgimigli, M, Costa, F, Lokhnygina, Y, Clare, RM, Wallentin, L, Moliterno, DJ, Armstrong, PW, White, HD, Held, C, Aylward, PE, van der Werf, F, Harrington, RA, Mahaffey, KW & Tricoci, P 2017, 'Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial', European Heart Journal, vol. 38, no. 11, pp. 804-+. https://doi.org/10.1093/eurheartj/ehw525

Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial. / Valgimigli, M (Marco); Costa, F (Frederico); Lokhnygina, Y et al.

In: European Heart Journal, Vol. 38, No. 11, 2017, p. 804-+.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial

AU - Valgimigli, M (Marco)

AU - Costa, F (Frederico)

AU - Lokhnygina, Y

AU - Clare, RM

AU - Wallentin, L

AU - Moliterno, DJ

AU - Armstrong, PW

AU - White, HD

AU - Held, C

AU - Aylward, PE

AU - van der Werf, F

AU - Harrington, RA

AU - Mahaffey, KW

AU - Tricoci, P

PY - 2017

Y1 - 2017

U2 - 10.1093/eurheartj/ehw525

DO - 10.1093/eurheartj/ehw525

M3 - Article

SN - 0195-668X

VL - 38

SP - 804-+

JO - European Heart Journal

JF - European Heart Journal

IS - 11

ER -

Valgimigli M, Costa F, Lokhnygina Y, Clare RM, Wallentin L, Moliterno DJ et al. Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial. European Heart Journal. 2017;38(11):804-+. doi: 10.1093/eurheartj/ehw525